Enfortumab vedotin-ejfv (Intravenous)
Generic name: enfortumab vedotin (en-FORT-ue-mab ve-DOE-tin - ejfv)
Drug class: Miscellaneous antineoplastics
Medically reviewed by Drugs.com. Last updated on Aug 13, 2021.
Warning: Serious Skin ReactionsEnfortumab vedotin-ejfv can cause severe and fatal cutaneous adverse reactions including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which occurred predominantly during the first cycle of treatment, but may occur later.Immediately withhold enfortumab vedotin-ejfv and consider referral for specialized care for suspected SJS or TEN or severe skin reactions.Permanently discontinue enfortumab vedotin-ejfv in patients with confirmed SJS or TEN; or Grade 4 or recurrent Grade 3 skin reactions .
Commonly used brand name(s)
In the U.S.
Available Dosage Forms:
- Powder for Solution
Therapeutic Class: Antineoplastic Agent
Pharmacologic Class: Enfortumab Vedotin
Uses for enfortumab vedotin-ejfv
Enfortumab vedotin-ejfv injection is used to treat urothelial cancer (bladder cancer) that has spread or cannot be removed by surgery in patients who have tried other cancer medicines (eg, immunotherapy medicine, platinum-containing cancer medicine) or in patients who are not able to receive a cancer medicine that contains cisplatin and have received one or more prior treatments.
Enfortumab vedotin-ejfv is to be given only by or under the supervision of your doctor.
Before using enfortumab vedotin-ejfv
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For enfortumab vedotin-ejfv, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to enfortumab vedotin-ejfv or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of enfortumab vedotin-ejfv injection in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of enfortumab vedotin-ejfv injection in the elderly.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Interactions with food/tobacco/alcohol
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other medical problems
The presence of other medical problems may affect the use of enfortumab vedotin-ejfv. Make sure you tell your doctor if you have any other medical problems, especially:
- Diabetes or
- Eye problems (eg, dry eyes, keratitis) or
- Hyperglycemia (high blood sugar) or
- Peripheral neuropathy (nerve problem)—Use with caution. May make these conditions worse.
- Liver disease, moderate or severe—Use with caution. The effects may be increased because of slower removal of the medicine from the body.
Proper use of enfortumab vedotin-ejfv
Medicines used to treat cancer are very strong and can have many side effects. Before receiving enfortumab vedotin-ejfv, make sure you understand all the risks and benefits. It is important for you to work closely with your doctor during your treatment.
A nurse or other trained health professional will give you enfortumab vedotin-ejfv in a medical facility. It is given through a needle placed into one of your veins. It must be given slowly, so the needle will have to remain in place for at least 30 minutes. The infusion will be given on Days 1, 8, and 15 of a 28-day cycle.
Enfortumab vedotin-ejfv comes with a patient information leaflet. Read and follow the instructions carefully. Ask your doctor if you have any questions.
Enfortumab vedotin-ejfv needs to be given on a fixed schedule. If you miss a dose or forget to use your medicine, call your doctor or pharmacist for instructions.
Precautions while using enfortumab vedotin-ejfv
It is very important that your doctor check your progress at regular visits to make sure that enfortumab vedotin-ejfv is working properly. Blood tests may be needed to check for unwanted effects.
Receiving enfortumab vedotin-ejfv while you are pregnant can harm your unborn baby. If you are a woman who can get pregnant, your doctor may do tests to make sure you are not pregnant before starting treatment. Use an effective form of birth control to keep from getting pregnant during treatment and for at least 2 months after your last dose. Males who are taking enfortumab vedotin-ejfv, with female partners who can become pregnant, must use effective birth control during and for at least 4 months after the last dose of enfortumab vedotin-ejfv. If you think you have become pregnant while using the medicine, tell your doctor right away.
If you plan to have children, talk with your doctor before using enfortumab vedotin-ejfv. Some men using enfortumab vedotin-ejfv have become infertile (unable to have children).
Serious skin reactions (eg, Stevens-Johnson syndrome, toxic epidermal necrolysis) can occur with enfortumab vedotin-ejfv. Check with your doctor right away if you have blistering, peeling, or loosening of the skin, chills, cough, diarrhea, itching, joint or muscle pain, red irritated eyes, red skin lesions often with a purple center, sore throat, sores, ulcers, or white spots in the mouth or on the lips, or unusual tiredness or weakness.
Enfortumab vedotin-ejfv may affect blood sugar levels. If you notice a change in the results of your blood or urine sugar tests or if you have any questions, check with your doctor.
Enfortumab vedotin-ejfv may cause pneumonitis (swelling of the lungs). Check with your doctor right away if you have chest pain, chills, cough, fever, general feeling of discomfort or illness, thickening of bronchial secretions, or trouble breathing.
Check with your doctor right away if you are having burning, numbness, tingling, or painful sensations, weakness in the arms, hands, legs, or feet, or unsteadiness. These could be symptoms of a condition called peripheral neuropathy.
Check with your doctor immediately if blurred vision, difficulty in reading, dry eyes, or any other change in vision occurs during or after treatment. Your doctor may want you to have your eyes checked by an ophthalmologist (eye doctor).
Tell your doctor if you have pain, redness, or swelling at the infusion site after receiving enfortumab vedotin-ejfv.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Enfortumab vedotin-ejfv side effects
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
- Blurred vision
- burning, dry, or itching eyes
- burning, numbness, tingling, or painful sensations
- discharge, excessive tearing
- dry eyes
- dry mouth
- eye redness, irritation, or pain
- flushed, dry skin
- fruit-like breath odor
- increased hunger
- increased thirst
- increased urination
- lack or loss of strength
- rash with flat lesions or small raised lesions on the skin
- redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid
- stomach pain
- trouble breathing
- unexplained weight loss
- unsteadiness or awkwardness
- unusual tiredness or weakness
- weakness in the arms, hands, legs, or feet
- Chest pain
- general feeling of discomfort or illness
- thickening of bronchial secretions
Incidence not known
- Blistering, peeling, or loosening of the skin
- joint or muscle pain
- red irritated eyes
- red skin lesions, often with a purple center
- redness, tenderness, itching, burning, or peeling of the skin
- sore throat
- sores, ulcers, or white spots in the mouth or on the lips
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Change in taste
- cracks in the skin
- decreased appetite
- dry skin
- hair loss or thinning of the hair
- loss of heat from the body
- loss of taste
- painful blisters on the trunk of the body
- red, swollen skin redness, swelling, or pain of the skin
- scaling of the skin on the hands and feet
- skin blisters
- tingling of the hands and feet
- ulceration of the skin
- Pain, redness, or swelling at the injection site
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
More about enfortumab vedotin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 3 Reviews
- Drug class: miscellaneous antineoplastics
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.